Groenland, Stefanie L. http://orcid.org/0000-0001-9918-2374
Martínez-Chávez, Alejandra
van Dongen, Marloes G. J.
Beijnen, Jos H.
Schinkel, Alfred H.
Huitema, Alwin D. R.
Steeghs, Neeltje
Article History
First Online: 8 October 2020
Declarations
:
: No funding has been received for the preparation of this review.
: Jos H. Beijnen is a patent holder (in part), stock holder (indirectly), and a part-time employee of Modra Pharmaceuticals BV. Modra Pharmaceuticals BV is a small spin-off company clinically developing oral pharmaceutical formulations of taxanes; none of these positions are related to the current review. Stefanie L. Groenland, Alejandra Martínez-Chávez, Marloes G.J. van Dongen, Alfred H. Schinkel, Alwin D.R. Huitema, and Neeltje Steeghs have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: SG and AM reviewed the available literature and wrote the manuscript. MvD, JB, AS, AH, and NS critically reviewed the manuscript.